|
|
 |
|
Viewing report
|
|
 |
 |
India Pharmaceuticals and Healthcare Report Q2 2008
Business Monitor International, March 2008, Pages: 101
Executive Summary India Pharmaceutical Industry SWOT India Political SWOT India Economic SWOT India Business Environment SWOT
India’s Pharmaceutical Business Environment Ratings Table: Asia Pacific Pharmaceutical Business Environment Rankings For Q208 Limits Of Potential Returns Risks To Realisation Of Returns
Market Summary Regulatory Environment Pharmacovigilance Recent Regulatory Developments IP Regime Table: History Of The Indian Patent System Deficiencies of IP Regime Recent IP Developments Patent Disputes Counterfeit Medicines Table: Anti-Counterfeiting Guidelines From The Organisation Of Pharmaceutical Producers Of India (OPPI) Pricing And Reimbursement Other Regulatory Developments
Industry Trends And Developments Epidemiology Healthcare Sector Pharmaceutical Industry Domestic Industry Developments Foreign Company Developments Retail Pharmacy Sector Table: Major Players In Indias Retail Pharmacy Sector
Foreign Co-operation Table: India - Asian FTA Situation Clinical Research Table: Clinical Trial Considerations In Asia Active Pharmaceutical Ingredients Table: APIs Manufactured By Hikal
Biotechnology Sector Recent Biotechnology Sector Developments Medical Devices Industry Forecast Scenario Overall Market Forecast Table: Drug Expenditure and Prescription Market Indicators (US$mn unless otherwise staed) Key Growth Factors - Industry Table: India - Health Expenditure Forecasts Key Growth Factors - Macroeconomic Table: India - Economic Activity Patented Market Forecast Table: India Patented Forecasts (US$mn unless otherwise stated) Generics Market Forecast Table: India Generics And Branded Market Forecast Indicators OTC Market Forecast Table: India - OTC Market Forecasts (US$mn unless otherwise stated) Export/Import Forecasts Table: India Imports And Exports Forecasts (US$bn) Other Healthcare Data Forecasts Table: India Healthcare Data Forecasts Key Risks To our Forecast Scenario Competitive Landscape.56 Table: Ranking Of Indian Drug-makers By Retail Sales, July 2007
Company Profiles
Leading Multinational Manufacturers - Pfizer - GlaxoSmithKline (GSK) - Novartis - Sanofi-Aventis - Merck & Co - Eili Lilly
Leading Indigenous Manufacturers - Ranbaxy Laboratories - Cipla - Dr Reddy’s Laboratories - Aurobindo Pharmaceutical - Venus Remedies - Granules India - Nicholas Piramal India - Zydus Cadila - Dishman Pharmaceuticals and Chemicals
BMI Forecast Modelling How We Generate Our Industry Forecasts Pharmaceutical Industry Pharmaceutical Business Environment Ratings Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Sources 0
Customers who bought this item also bought
India Pharmaceuticals and Healthcare Report Q3 2008
India Pharmaceuticals and Healthcare Report Q4 2009
India Pharmaceuticals and Healthcare Report Q1 2008
Indian Pharmaceutical Industry
India: Pharmaceutical
The Pharmaceutical Market: India
The Indian Pharmaceutical Industry 2009: Diversification, Expansion & Ambitions
Ranbaxy Generics Company Intelligence Report
Slovakia Pharmaceuticals and Healthcare Report Q4 2008
The Indian Pharmaceutical Industry: Expansion & Ambitions + Indian Pharma Industry Tracker
The Indian Pharmaceutical Industry: Expansion & Ambitions
South Korea Pharmaceuticals and Healthcare Report Q3 2008
|
 |
|
|